SS Innovations International (SSII) announced that its SSi Mantra surgical robotic system will be featured at the 2026 Society of Robotic Surgery Annual Meeting, scheduled for July 23-26 in Hollywood, Florida. The event will showcase the system through breakout sessions and a live broadcast of a remote partial nephrectomy, demonstrating the platform's telesurgery capabilities.
The live procedure will be performed by Dr. Amitabh Singh from SSII's headquarters in Gurugram, India, on a patient at Rajeev Gandhi Cancer Institute and Research Centre in New Delhi, highlighting the system's ability to enable remote surgical care across significant distances. Chairman and CEO Dr. Sudhir Srivastava will participate as a speaker and panelist in sessions covering telesurgery, robotic surgery adoption, regulatory frameworks, and global access to robotic care.
As of July 6, 2026, the SSi Mantra system had been utilized in 12,375 procedures spanning more than 170 procedure types, including 653 cardiac procedures, 178 telesurgeries, and 225 pediatric surgeries. Additionally, approximately 2,100 physicians have been trained on the platform. These figures underscore the system's expanding adoption and the company's progress in making robotic surgery more accessible.
The announcement is significant because it demonstrates SSII's continued advancement in the surgical robotics field, particularly in telesurgery, which has the potential to bridge gaps in surgical access for underserved regions. The company's focus on affordability and user-friendly design aligns with broader healthcare goals to democratize robotic surgery. For further details, the full press release is available at https://ibn.fm/YYYKE.
SS Innovations International develops and markets the SSi Mantra surgical robotic system and the SSi Mudra suite of surgical instruments, aiming to make robotic surgery cost-effective and widely available. The company, headquartered in India, plans to expand its global presence. This event serves as a platform to highlight the system's technical capabilities and real-world impact, potentially influencing adoption and regulatory discussions in the field.
